Summit Therapeutics Inc. — Director's Dealing 2021

Nov 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Summit Therapeutics Inc. (SMMT)
CIK: 0001599298
Period of Report: 2021-11-11

Reporting Person: Maranian Jeffrey R (VP Corporate Controller)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-11	Stock Option (right to buy)	$5.28	A	50000	Acquired	2031-11-11	Common Stock (50000.0)	Direct

Footnotes

F1: The option was granted on November 11, 2021. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on November 11, 2022.

F2: Not applicable.